Wall Street Journal J&J’s Sales and Profit Rise on Strong Cancer and Autoimmune Drug Sales This post was originally published on this site. The healthcare company’s forecast for 2026 tops Wall Street’s expectations. By Peter LoftusJanuary 21, 2026January 22, 2026No comment
